首页> 外文OA文献 >Clinical acceptability study in patients suffering from chronic venous disease (CVD) comparing micronized purified flavonoid fraction (MPFF) 1000 mg, one tablet daily, to MPFF 500 mg tablet twice a day

【2h】

Clinical acceptability study in patients suffering from chronic venous disease (CVD) comparing micronized purified flavonoid fraction (MPFF) 1000 mg, one tablet daily, to MPFF 500 mg tablet twice a day

机译：患有慢性静脉疾病（CVD）患者的临床可接受性研究比较微粉化纯化的黄酮馏分（MPFF）1000毫克，每日一片，一种片剂，每天两次PMF 500mg片剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alexander Kirienko;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease [J] . Shelygin Yuri, Krivokapic Zoran, Frolov S. A., Current medical research and opinion . 2016,第11期

机译：微粉状纯化黄酮类成分1000毫克片剂与500毫克片剂在急性痔疮患者中的临床可接受性研究
2. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial [J] . Carpentier Patrick, van Bellen Bonno, Karetova Debora, International angiology: A journal of the International Union of Angiology . 2017,第5期

机译：患有症状慢性静脉疾病患者的新1000mg悬浮液与两次每日500mg片剂的临床疗效和安全性：随机对照试验
3. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence [J] . Ulloa Jorge H. Advances in therapy. . 2019,第1Suppla期

机译：微粉化纯化的类黄酮级分（MPFF），用于患有慢性静脉疾病的患者：对新证据的审查
4. Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial [O] . Kirill Lobastov, Ilya Schastlivtsev, Victor Barinov -1

机译：微粉化纯化的类黄酮组分与利伐沙班一起使用可改善股pop静脉血栓形成的临床和超声结果：一项临床试验的结果
5. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence [O] . Jorge H. Ulloa 2019

机译：微粉化纯化的黄酮级分（MPFF），用于患有慢性静脉疾病的患者：对新证据的审查

Clinical acceptability study in patients suffering from chronic venous disease (CVD) comparing micronized purified flavonoid fraction (MPFF) 1000 mg, one tablet daily, to MPFF 500 mg tablet twice a day

著录项

引文网络

相似文献

相关主题

期刊订阅